ARCHIVES

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

Organ Systems Program Adds Workshops On Lung, Colorectal Cancer

January 26, 1990

Surveillance Colonoscopy Cost-Effective For High-Risk

July 30, 2010

Komen Foundation Awards New Grants

October 20, 1995

DCBD Board Like Organ Systems Program But Not RFAs, Okays Program Announcement, Contract Concepts

November 20, 1987

New Chairman Of Core Grant Review Committee Has Some Advice for Applicants

May 5, 1978

Levine Leaves Presidency Of Rockefeller University.

February 15, 2002